Cargando…
Restricted Use of Erythropoiesis-Stimulating Agent is Safe and Associated with Deferred Dialysis Initiation in Stage 5 Chronic Kidney Disease
The effect of erythropoiesis-stimulating agent (ESA) on dialysis initiation in advanced chronic kidney disease (CKD) patients is not clear. We retrospectively analyzed the outcome of dialysis initiation in a stage 5 CKD cohort with ESA reimbursement limited to the maximal standardized monthly ESA do...
Autores principales: | Pan, Szu-Yu, Chiang, Wen-Chih, Chen, Ping-Min, Liu, Heng-Hsiu, Chou, Yu-Hsiang, Lai, Tai-Shuan, Lai, Chun-Fu, Chiu, Yen-Ling, Lin, Wan-Yu, Chen, Yung-Ming, Chu, Tzong-Shinn, Lin, Shuei-Liong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341043/ https://www.ncbi.nlm.nih.gov/pubmed/28272424 http://dx.doi.org/10.1038/srep44013 |
Ejemplares similares
-
Outcomes of coronavirus 2019 infection in patients with chronic kidney disease: a systematic review and meta-analysis
por: Lin, Yi-Chih, et al.
Publicado: (2021) -
The impact of baseline glomerular filtration rate on subsequent changes of glomerular filtration rate in patients with chronic kidney disease
por: Lin, Yi-Chih, et al.
Publicado: (2021) -
Predialysis trajectories of estimated GFR and concurrent trends of Chronic Kidney Disease-relevant biomarkers
por: Tsao, Hsiao-Mei, et al.
Publicado: (2023) -
Angiopoietin-2 Is Associated with Albuminuria and Microinflammation in Chronic Kidney Disease
por: Chang, Fan-Chi, et al.
Publicado: (2013) -
Humeral and cellular immune responses to SARS-CoV-2 vaccination in patients on peritoneal dialysis
por: Yu, Zhi-Ye, et al.
Publicado: (2023)